Mar 29, 2019
Arix Bioscience plc - Autolus Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019
Feb 25, 2019
Autolus Therapeutics Reports Financial and Operational Results for the Transition Period from October 1 to December 31, 2018
Feb 19, 2019
Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial
Feb 19, 2019
Autolus Therapeutics Announces Updated Results from Ongoing CARPALL Trial of Pediatric Acute Lymphoblastic Leukemia Presented at the EHA 1st European CAR T Cell Meeting in Paris
Jan 14, 2019
Autolus Therapeutics Enters Lease with Alexandria Real Estate Equities, Inc. for Future Commercial-Scale Manufacturing Site and U.S. Headquarters
Dec 03, 2018
Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes
Dec 03, 2018
Arix Bioscience plc: Autolus Presents Initial AUTO3 Clinical Data at ASH
Dec 02, 2018
Autolus Therapeutics Presents Initial AUTO3 Clinical Data from Phase 1/2 Clinical Trials in B cell Malignancies at the 60th ASH Annual Meeting
Nov 23, 2018
Autolus Therapeutics Submits Fiscal Year 2018 Form 20-F
Nov 02, 2018
Autolus Therapeutics to Present New Data at the ASH Annual Meeting
Nov 01, 2018
Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 60th ASH Annual Meeting
Oct 30, 2018
Autolus Therapeutics to Present at the Jefferies 2018 London Healthcare Conference
Oct 17, 2018
Adam Hacker, PhD Joins Autolus as Senior Vice President for Regulatory Affairs and Quality
Aug 30, 2018
Autolus to Present at Upcoming Investor Conferences